United States Cellular Corporat Logo

United States Cellular Corporat

UZF

(2.2)
Stock Price

23,30 USD

1.22% ROA

1.55% ROE

66.52x PER

Market Cap.

4.788.505.207,00 USD

65.05% DER

0% Yield

1.88% NPM

United States Cellular Corporat Stock Analysis

United States Cellular Corporat Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

United States Cellular Corporat Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.34x), the stock offers substantial upside potential at a bargain price.

2 ROE

The stock's ROE falls within an average range (1.57%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (9.61%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 DER

The stock maintains a fair debt to equity ratio (85%), indicating a reasonable balance between the money it owes and the ownership it possesses.

5 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

6 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

7 Dividend

Investors can rely on the company's consistent dividend payments over the past three years, offering a steady stream of returns.

8 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (54.316) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

United States Cellular Corporat Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

United States Cellular Corporat Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

United States Cellular Corporat Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

United States Cellular Corporat Revenue
Year Revenue Growth
1986 7.000.000
1987 10.300.000 32.04%
1988 18.100.000 43.09%
1989 40.300.000 55.09%
1990 63.000.000 36.03%
1991 99.500.000 36.68%
1992 164.100.000 39.37%
1993 247.300.000 33.64%
1994 332.400.000 25.6%
1995 492.400.000 32.49%
1996 707.800.000 30.43%
1997 877.000.000 19.29%
1998 1.162.500.000 24.56%
1999 1.417.200.000 17.97%
2000 1.716.640.000 17.44%
2001 1.894.830.000 9.4%
2002 2.184.478.000 13.26%
2003 2.582.783.000 15.42%
2004 2.837.619.000 8.98%
2005 3.035.887.000 6.53%
2006 3.473.155.000 12.59%
2007 3.946.264.000 11.99%
2008 4.243.185.000 7%
2009 4.214.611.000 -0.68%
2010 4.177.681.000 -0.88%
2011 4.343.346.000 3.81%
2012 4.452.084.000 2.44%
2013 3.918.836.000 -13.61%
2014 3.892.747.000 -0.67%
2015 3.996.853.000 2.6%
2016 3.939.000.000 -1.47%
2017 3.890.000.000 -1.26%
2018 3.967.000.000 1.94%
2019 4.022.000.000 1.37%
2020 4.037.000.000 0.37%
2021 4.122.000.000 2.06%
2022 4.169.000.000 1.13%
2023 3.852.000.000 -8.23%
2023 3.906.000.000 1.38%
2024 3.708.000.000 -5.34%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

United States Cellular Corporat Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

United States Cellular Corporat General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 163.300.000 100%
1995 234.800.000 30.45%
1996 320.200.000 26.67%
1997 379.600.000 15.65%
1998 491.600.000 22.78%
1999 598.500.000 17.86%
2000 668.468.000 10.47%
2001 731.818.000 8.66%
2002 874.125.000 16.28%
2003 1.004.655.000 12.99%
2004 1.122.700.000 10.51%
2005 1.212.874.000 7.43%
2006 1.399.561.000 13.34%
2007 1.555.639.000 10.03%
2008 1.701.050.000 8.55%
2009 1.748.760.000 2.73%
2010 1.796.624.000 2.66%
2011 1.779.203.000 -0.98%
2012 1.764.933.000 -0.81%
2013 1.677.395.000 -5.22%
2014 1.591.914.000 -5.37%
2015 1.493.730.000 -6.57%
2016 1.480.000.000 -0.93%
2017 1.412.000.000 -4.82%
2018 1.388.000.000 -1.73%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

United States Cellular Corporat EBITDA
Year EBITDA Growth
1986 -6.200.000
1987 -7.100.000 12.68%
1988 -8.300.000 14.46%
1989 -9.000.000 7.78%
1990 -2.700.000 -233.33%
1991 -6.800.000 60.29%
1992 38.400.000 117.71%
1993 14.800.000 -159.46%
1994 51.000.000 70.98%
1995 6.600.000 -672.73%
1996 2.400.000 -175%
1997 150.200.000 98.4%
1998 123.900.000 -21.23%
1999 187.000.000 33.74%
2000 416.730.000 55.13%
2001 571.925.000 27.14%
2002 882.407.000 35.19%
2003 596.605.000 -47.9%
2004 574.588.000 -3.83%
2005 645.329.000 10.96%
2006 857.748.000 24.76%
2007 901.436.000 4.85%
2008 1.089.005.000 17.22%
2009 1.011.462.000 -7.67%
2010 873.554.000 -15.79%
2011 939.425.000 7.01%
2012 898.907.000 -4.51%
2013 615.204.000 -46.12%
2014 480.325.000 -28.08%
2015 852.152.000 43.63%
2016 816.000.000 -4.43%
2017 820.000.000 0.49%
2018 963.000.000 14.85%
2019 1.015.000.000 5.12%
2020 1.063.000.000 4.52%
2021 1.054.000.000 -0.85%
2022 956.000.000 -10.25%
2023 740.000.000 -29.19%
2023 978.000.000 24.34%
2024 940.000.000 -4.04%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

United States Cellular Corporat Gross Profit
Year Gross Profit Growth
1986 5.800.000
1987 5.500.000 -5.45%
1988 6.800.000 19.12%
1989 16.600.000 59.04%
1990 32.600.000 49.08%
1991 56.200.000 41.99%
1992 112.100.000 49.87%
1993 155.300.000 27.82%
1994 246.100.000 36.9%
1995 367.100.000 32.96%
1996 515.000.000 28.72%
1997 639.500.000 19.47%
1998 874.500.000 26.87%
1999 1.083.200.000 19.27%
2000 1.226.479.000 11.68%
2001 1.349.688.000 9.13%
2002 1.506.445.000 10.41%
2003 1.651.474.000 8.78%
2004 1.787.598.000 7.61%
2005 1.921.588.000 6.97%
2006 2.264.569.000 15.15%
2007 2.588.964.000 12.53%
2008 3.499.779.000 26.02%
2009 2.675.001.000 -30.83%
2010 2.579.769.000 -3.69%
2011 2.631.667.000 1.97%
2012 2.569.332.000 -2.43%
2013 2.156.401.000 -19.15%
2014 1.930.167.000 -11.72%
2015 2.169.001.000 11.01%
2016 2.098.000.000 -3.38%
2017 2.087.000.000 -0.53%
2018 2.178.000.000 4.18%
2019 2.238.000.000 2.68%
2020 2.244.000.000 0.27%
2021 2.214.000.000 -1.36%
2022 2.198.000.000 -0.73%
2023 2.940.000.000 25.24%
2023 2.178.000.000 -34.99%
2024 1.400.000.000 -55.57%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

United States Cellular Corporat Net Profit
Year Net Profit Growth
1986 -2.600.000
1987 -4.100.000 36.59%
1988 -6.600.000 37.88%
1989 -18.300.000 63.93%
1990 -14.700.000 -24.49%
1991 -24.400.000 39.75%
1992 6.200.000 493.55%
1993 -25.400.000 124.41%
1994 16.400.000 254.88%
1995 99.700.000 83.55%
1996 129.900.000 23.25%
1997 111.500.000 -16.5%
1998 216.900.000 48.59%
1999 300.800.000 27.89%
2000 192.907.000 -55.93%
2001 173.876.000 -10.95%
2002 -14.288.000 1316.94%
2003 60.774.000 123.51%
2004 109.021.000 44.25%
2005 134.748.000 19.09%
2006 179.490.000 24.93%
2007 314.734.000 42.97%
2008 32.990.000 -854.03%
2009 216.008.000 84.73%
2010 132.324.000 -63.24%
2011 175.041.000 24.4%
2012 111.006.000 -57.69%
2013 140.038.000 20.73%
2014 -42.812.000 427.1%
2015 241.347.000 117.74%
2016 48.000.000 -402.81%
2017 12.000.000 -300%
2018 150.000.000 92%
2019 127.000.000 -18.11%
2020 229.000.000 44.54%
2021 155.000.000 -47.74%
2022 30.000.000 -416.67%
2023 92.000.000 67.39%
2023 54.000.000 -70.37%
2024 68.000.000 20.59%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

United States Cellular Corporat Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 0
1987 0 0%
1988 0 0%
1989 -1 0%
1990 -1 0%
1991 -1 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 1 100%
1996 2 0%
1997 1 0%
1998 2 50%
1999 3 33.33%
2000 2 -50%
2001 2 0%
2002 0 0%
2003 0 0%
2004 1 100%
2005 2 0%
2006 2 50%
2007 4 33.33%
2008 0 0%
2009 2 100%
2010 2 -100%
2011 2 50%
2012 1 -100%
2013 2 0%
2014 -1 0%
2015 3 100%
2016 1 0%
2017 0 0%
2018 2 100%
2019 1 0%
2020 3 50%
2021 2 -100%
2022 0 0%
2023 1 100%
2023 1 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

United States Cellular Corporat Free Cashflow
Year Free Cashflow Growth
1989 -14.900.000
1990 -20.000.000 25.5%
1991 -75.300.000 73.44%
1992 -49.800.000 -51.2%
1993 -49.600.000 -0.4%
1994 -73.900.000 32.88%
1995 -92.800.000 20.37%
1996 -81.900.000 -13.31%
1997 -55.700.000 -47.04%
1998 -80.600.000 30.89%
1999 54.700.000 247.35%
2000 226.022.000 75.8%
2001 -47.465.000 576.19%
2002 -78.556.000 39.58%
2003 5.296.000 1583.31%
2004 -123.673.000 104.28%
2005 55.595.000 322.45%
2006 113.663.000 51.09%
2007 297.583.000 61.8%
2008 337.187.000 11.75%
2009 335.050.000 -0.64%
2010 291.155.000 -15.08%
2011 216.064.000 -34.75%
2012 -49.799.000 533.87%
2013 -443.505.000 88.77%
2014 -470.891.000 5.82%
2015 -311.286.000 -51.27%
2016 5.000.000 6325.72%
2017 -185.000.000 102.7%
2018 189.000.000 197.88%
2019 -192.000.000 198.44%
2020 47.000.000 508.51%
2021 -1.244.000.000 103.78%
2022 -355.000.000 -250.42%
2023 128.000.000 377.34%
2023 226.000.000 43.36%
2024 172.000.000 -31.4%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

United States Cellular Corporat Operating Cashflow
Year Operating Cashflow Growth
1989 -7.300.000
1990 -5.500.000 -32.73%
1991 -18.900.000 70.9%
1992 3.500.000 640%
1993 35.300.000 90.08%
1994 84.300.000 58.13%
1995 115.900.000 27.26%
1996 137.500.000 15.71%
1997 222.100.000 38.09%
1998 311.100.000 28.61%
1999 333.200.000 6.63%
2000 521.330.000 36.09%
2001 440.348.000 -18.39%
2002 620.080.000 28.99%
2003 621.655.000 0.25%
2004 518.408.000 -19.92%
2005 642.170.000 19.27%
2006 693.448.000 7.39%
2007 863.078.000 19.65%
2008 922.777.000 6.47%
2009 881.808.000 -4.65%
2010 874.289.000 -0.86%
2011 987.862.000 11.5%
2012 899.291.000 -9.85%
2013 290.897.000 -209.14%
2014 172.342.000 -68.79%
2015 555.114.000 68.95%
2016 501.000.000 -10.8%
2017 469.000.000 -6.82%
2018 709.000.000 33.85%
2019 724.000.000 2.07%
2020 1.237.000.000 41.47%
2021 802.000.000 -54.24%
2022 832.000.000 3.61%
2023 866.000.000 3.93%
2023 329.000.000 -163.22%
2024 313.000.000 -5.11%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

United States Cellular Corporat Capital Expenditure
Year Capital Expenditure Growth
1989 7.600.000
1990 14.500.000 47.59%
1991 56.400.000 74.29%
1992 53.300.000 -5.82%
1993 84.900.000 37.22%
1994 158.200.000 46.33%
1995 208.700.000 24.2%
1996 219.400.000 4.88%
1997 277.800.000 21.02%
1998 391.700.000 29.08%
1999 278.500.000 -40.65%
2000 295.308.000 5.69%
2001 487.813.000 39.46%
2002 698.636.000 30.18%
2003 616.359.000 -13.35%
2004 642.081.000 4.01%
2005 586.575.000 -9.46%
2006 579.785.000 -1.17%
2007 565.495.000 -2.53%
2008 585.590.000 3.43%
2009 546.758.000 -7.1%
2010 583.134.000 6.24%
2011 771.798.000 24.44%
2012 949.090.000 18.68%
2013 734.402.000 -29.23%
2014 643.233.000 -14.17%
2015 866.400.000 25.76%
2016 496.000.000 -74.68%
2017 654.000.000 24.16%
2018 520.000.000 -25.77%
2019 916.000.000 43.23%
2020 1.190.000.000 23.03%
2021 2.046.000.000 41.84%
2022 1.187.000.000 -72.37%
2023 738.000.000 -60.84%
2023 103.000.000 -616.5%
2024 141.000.000 26.95%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

United States Cellular Corporat Equity
Year Equity Growth
1986 12.600.000
1987 30.200.000 58.28%
1988 86.300.000 65.01%
1989 83.700.000 -3.11%
1990 117.000.000 28.46%
1991 386.700.000 69.74%
1992 481.100.000 19.62%
1993 974.500.000 50.63%
1994 1.137.200.000 14.31%
1995 1.374.800.000 17.28%
1996 1.527.500.000 10%
1997 1.683.200.000 9.25%
1998 1.993.800.000 15.58%
1999 2.315.600.000 13.9%
2000 2.249.504.000 -2.94%
2001 2.382.101.000 5.57%
2002 2.470.102.000 3.56%
2003 2.556.271.000 3.37%
2004 2.628.463.000 2.75%
2005 2.797.182.000 6.03%
2006 3.029.979.000 7.68%
2007 3.239.552.000 6.47%
2008 3.255.798.000 0.5%
2009 3.455.997.000 5.79%
2010 3.534.101.000 2.21%
2011 3.676.922.000 3.88%
2012 3.795.740.000 3.13%
2013 3.410.133.000 -11.31%
2014 3.313.752.000 -2.91%
2015 3.571.853.000 7.23%
2016 3.646.000.000 2.03%
2017 3.688.000.000 1.14%
2018 4.078.000.000 9.56%
2019 4.221.000.000 3.39%
2020 4.436.000.000 4.85%
2021 4.574.000.000 3.02%
2022 4.582.000.000 0.17%
2023 4.615.000.000 0.72%
2023 4.654.000.000 0.84%
2024 4.706.000.000 1.1%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

United States Cellular Corporat Assets
Year Assets Growth
1986 40.300.000
1987 64.300.000 37.33%
1988 121.000.000 46.86%
1989 172.600.000 29.9%
1990 279.800.000 38.31%
1991 616.800.000 54.64%
1992 855.600.000 27.91%
1993 1.245.400.000 31.3%
1994 1.534.800.000 18.86%
1995 1.880.100.000 18.37%
1996 2.085.900.000 9.87%
1997 2.508.900.000 16.86%
1998 3.047.600.000 17.68%
1999 3.500.100.000 12.93%
2000 3.467.034.000 -0.95%
2001 3.725.014.000 6.93%
2002 4.699.841.000 20.74%
2003 4.923.647.000 4.55%
2004 5.181.927.000 4.98%
2005 5.434.028.000 4.64%
2006 5.680.616.000 4.34%
2007 5.611.874.000 -1.22%
2008 5.566.042.000 -0.82%
2009 5.745.217.000 3.12%
2010 5.933.610.000 3.18%
2011 6.327.976.000 6.23%
2012 6.587.450.000 3.94%
2013 6.445.708.000 -2.2%
2014 6.487.268.000 0.64%
2015 7.059.978.000 8.11%
2016 7.110.000.000 0.7%
2017 6.841.000.000 -3.93%
2018 7.274.000.000 5.95%
2019 8.164.000.000 10.9%
2020 9.681.000.000 15.67%
2021 10.341.000.000 6.38%
2022 11.119.000.000 7%
2023 749.000.000 -1384.51%
2023 10.750.000.000 93.03%
2024 10.639.000.000 -1.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

United States Cellular Corporat Liabilities
Year Liabilities Growth
1986 27.700.000
1987 34.100.000 18.77%
1988 34.700.000 1.73%
1989 88.900.000 60.97%
1990 162.800.000 45.39%
1991 230.100.000 29.25%
1992 374.500.000 38.56%
1993 270.900.000 -38.24%
1994 397.600.000 31.87%
1995 505.300.000 21.31%
1996 558.400.000 9.51%
1997 825.700.000 32.37%
1998 1.053.800.000 21.65%
1999 1.184.500.000 11.03%
2000 1.217.530.000 2.71%
2001 1.342.913.000 9.34%
2002 2.229.739.000 39.77%
2003 2.367.376.000 5.81%
2004 2.553.464.000 7.29%
2005 2.636.846.000 3.16%
2006 2.650.637.000 0.52%
2007 2.372.322.000 -11.73%
2008 2.310.244.000 -2.69%
2009 2.289.220.000 -0.92%
2010 2.399.509.000 4.6%
2011 2.651.054.000 9.49%
2012 2.791.710.000 5.04%
2013 3.035.575.000 8.03%
2014 3.173.516.000 4.35%
2015 3.488.125.000 9.02%
2016 3.464.000.000 -0.7%
2017 3.153.000.000 -9.86%
2018 3.196.000.000 1.35%
2019 3.943.000.000 18.94%
2020 5.245.000.000 24.82%
2021 5.767.000.000 9.05%
2022 6.537.000.000 11.78%
2023 6.130.000.000 -6.64%
2023 6.096.000.000 -0.56%
2024 5.933.000.000 -2.75%

United States Cellular Corporat Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
44.65
Net Income per Share
0.84
Price to Earning Ratio
66.52x
Price To Sales Ratio
1.25x
POCF Ratio
4.83
PFCF Ratio
14.6
Price to Book Ratio
1.02
EV to Sales
2.2
EV Over EBITDA
8.72
EV to Operating CashFlow
8.5
EV to FreeCashFlow
25.72
Earnings Yield
0.02
FreeCashFlow Yield
0.07
Market Cap
4,79 Bil.
Enterprise Value
8,44 Bil.
Graham Number
32
Graham NetNet
-57.35

Income Statement Metrics

Net Income per Share
0.84
Income Quality
13.59
ROE
0.02
Return On Assets
0.01
Return On Capital Employed
0.02
Net Income per EBT
0.49
EBT Per Ebit
0.78
Ebit per Revenue
0.05
Effective Tax Rate
0.45

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.42
Operating Profit Margin
0.05
Pretax Profit Margin
0.04
Net Profit Margin
0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
11.53
Free CashFlow per Share
3.81
Capex to Operating CashFlow
0.67
Capex to Revenue
0.17
Capex to Depreciation
0.95
Return on Invested Capital
0.01
Return on Tangible Assets
0.01
Days Sales Outstanding
90.49
Days Payables Outstanding
48
Days of Inventory on Hand
25.61
Receivables Turnover
4.03
Payables Turnover
7.6
Inventory Turnover
14.25
Capex per Share
7.72

Balance Sheet

Cash per Share
2,50
Book Value per Share
54,72
Tangible Book Value per Share
-0.1
Shareholders Equity per Share
54.36
Interest Debt per Share
37.53
Debt to Equity
0.65
Debt to Assets
0.29
Net Debt to EBITDA
3.77
Current Ratio
1.55
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-4,56 Bil.
Invested Capital
8649000000
Working Capital
0,49 Bil.
Intangibles to Total Assets
0.44
Average Receivables
0,94 Bil.
Average Payables
0,25 Bil.
Average Inventory
159000000
Debt to Market Cap
0.64

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

United States Cellular Corporat Dividends
Year Dividends Growth
2021 1
2022 1 100%
2023 1 0%
2024 1 0%

United States Cellular Corporat Profile

About United States Cellular Corporat

United States Cellular Corp. engages in the provision of wireless telecommunication services. Its products include smartphones, tablets, vehicle routers, and accessories. It offers Internet plans, prepaid and postpaid plans, and roaming services. The company was founded by Leroy T. Carlson in 1983 and is headquartered in Chicago, IL.

CEO
Laurent C. Therivel
Employee
4.300
Address

Chicago,

United States Cellular Corporat Executives & BODs

United States Cellular Corporat Executives & BODs
# Name Age

United States Cellular Corporat Competitors